Publications

Found 251 results
Filters: First Letter Of Last Name is B  [Clear All Filters]
2015
Topka S, Vijai J, Walsh MF, Jacobs L, Maria A, Villano D, Gaddam P, Wu G, McGee RB, Quinn E et al..  2015.  Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.. PLoS Genet. 11(6):e1005262.
Bergstrom KSB, Morampudi V, Chan JM, Bhinder G, Lau J, Yang H, Ma C, Huang T, Ryz N, Sham HPan et al..  2015.  Goblet Cell Derived RELM-β Recruits CD4+ T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation.. PLoS Pathog. 11(8):e1005108.
Bergstrom KSB, Morampudi V, Chan JM, Bhinder G, Lau J, Yang H, Ma C, Huang T, Ryz N, Sham HPan et al..  2015.  Goblet Cell Derived RELM-β Recruits CD4+ T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation.. PLoS Pathog. 11(8):e1005108.
Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, Thome JJ, Farber DL, Lutfy K, Seale P et al..  2015.  Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity.. Nature. 519(7542):242-6.
Wagage S, Pritchard GHarms, Dawson L, Buza EL, Sonnenberg GF, Hunter CA.  2015.  The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection.. PLoS One. 10(5):e0128335.
Chen L, He Z, Slinger E, Bongers G, T Lapenda L, Pacer ME, Jiao J, Beltrao MF, Soto AJ, Harpaz N et al..  2015.  IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology.. Mucosal Immunol. 8(2):390-402.
Chen L, He Z, Slinger E, Bongers G, T Lapenda L, Pacer ME, Jiao J, Beltrao MF, Soto AJ, Harpaz N et al..  2015.  IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology.. Mucosal Immunol. 8(2):390-402.
Chen L, He Z, Slinger E, Bongers G, T Lapenda L, Pacer ME, Jiao J, Beltrao MF, Soto AJ, Harpaz N et al..  2015.  IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology.. Mucosal Immunol. 8(2):390-402.
Brestoff JR, Artis D.  2015.  Immune regulation of metabolic homeostasis in health and disease.. Cell. 161(1):146-60.
Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J, Withers DR, Hugues S, Farrar MA, Reith W et al..  2015.  Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.. Science. 348(6238):1031-5.
Kelsen JR, Baldassano RN, Artis D, Sonnenberg GF.  2015.  Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease.. Cell Mol Gastroenterol Hepatol. 1(5):462-476.
Bu P, Wang L, Chen K-Y, Rakhilin N, Sun J, Closa A, Tung K-L, King S, Varanko AKristine, Xu Y et al..  2015.  miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.. Nat Commun. 6:6879.
Tang J, Iliev ID, Brown J, Underhill DM, Funari VA.  2015.  Mycobiome: Approaches to analysis of intestinal fungi.. J Immunol Methods. 421:112-21.
Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen W-P, Mo A, Tucker C, Bhattacharya A et al..  2015.  A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.. Cancer Prev Res (Phila). 8(3):222-30.
Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen W-P, Mo A, Tucker C, Bhattacharya A et al..  2015.  A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.. Cancer Prev Res (Phila). 8(3):222-30.
Müller S, Wolf AJ, Iliev ID, Berg BL, Underhill DM, Liu GY.  2015.  Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates Immunopathology.. Cell Host Microbe. 18(5):604-12.
Hirten R, Longman RS, Bosworth BP, Steinlauf A, Scherl E.  2015.  Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease.. Am J Gastroenterol. 110(12):1737-8.
2016
Campisi L, Barbet G, Ding Y, Esplugues E, Flavell RA, J Blander M.  2016.  Apoptosis in response to microbial infection induces autoreactive TH17 cells.. Nat Immunol. 17(9):1084-92.
Campisi L, Barbet G, Ding Y, Esplugues E, Flavell RA, J Blander M.  2016.  Apoptosis in response to microbial infection induces autoreactive TH17 cells.. Nat Immunol. 17(9):1084-92.
Monticelli LA, Buck MD, Flamar A-L, Saenz SA, Wojno EDTait, Yudanin NA, Osborne LC, Hepworth MR, Tran SV, Rodewald H-R et al..  2016.  Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation.. Nat Immunol. 17(6):656-65.
J Blander M.  2016.  The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.. Immunol Rev. 272(1):65-79.
Legarda D, Justus SJ, Ang RL, Rikhi N, Li W, Moran TM, Zhang J, Mizoguchi E, Zelic M, Kelliher MA et al..  2016.  CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.. Cell Rep. 15(11):2449-61.
J Blander M.  2016.  Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease.. FEBS J. 283(14):2720-30.
Cummings RJ, Barbet G, Bongers G, Hartmann BM, Gettler K, Muniz L, Furtado GC, Cho J, Lira SA, J Blander M.  2016.  Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs.. Nature. 539(7630):565-569.
Cummings RJ, Barbet G, Bongers G, Hartmann BM, Gettler K, Muniz L, Furtado GC, Cho J, Lira SA, J Blander M.  2016.  Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs.. Nature. 539(7630):565-569.